NHD Global
Healing & Tissue Repair · Source-reviewed dossier
Source-Reviewed Research Dossier
KPV is the C-terminal Lys-Pro-Val tripeptide of α-melanocyte-stimulating hormone. It is studied in epithelial, inflammatory and gastrointestinal delivery models, but public evidence remains predominantly preclinical.
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; the current product specification and lot COA control.
Product identity
Literature reference parameters
Identity safeguard Reference identifiers above describe the literature compound record. The supplied form, formula, molecular weight, purity and storage conditions must be verified against the product-specific specification and lot COA.
A target-to-pathway view grounded in the linked research records.
Reported research findings
Reported outcomes are paired with their experimental model and evidence boundary.
A 2025 study reported reduced apoptosis and inflammatory signaling in a fine-dust-exposed keratinocyte model.
In-vitro exposure cannot establish topical or systemic human outcomes.
Read the primary studyKPV-loaded nanoparticles in a polysaccharide hydrogel were evaluated in a mouse colitis model.
The delivery system and animal model are integral to the result.
Read the primary studyCatalog options
Pack-level catalog data; lot-level controls remain document-specific.
Single-component peptide · 5 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Request by lot: CoA, HPLC purity and MS identity
Single-component peptide · 10 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Request by lot: CoA, HPLC purity and MS identity
Document availability is stated honestly and can vary by catalog variant or lot.
Analytical interpretation
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Published studies and regulatory records, not customer testimonials or usage guidance.
In-vitro exposure cannot establish topical or systemic human outcomes.
View primary recordThe delivery system and animal model are integral to the result.
View primary recordThird-party publications selected for direct relevance.
Cell study. 2025. PMID 40073467.
Laroui H, et al. Gastroenterology. 2010. PMID 19909746.
Concise answers for researchers comparing identity, evidence and catalog variants.
KPV is the C-terminal Lys-Pro-Val tripeptide of α-melanocyte-stimulating hormone. It is studied in epithelial, inflammatory and gastrointestinal delivery models, but public evidence remains predominantly preclinical.
The available evidence includes cell work and targeted-delivery animal studies rather than controlled human trials.
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.
Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.
Knowledge center
Owned educational content connected to this family.
KPV research spans keratinocyte stress models and targeted colon-delivery systems. The published effects are preclinical, and FDA states that it has not identified human…
Updated September 8, 2026
KPV is the tripeptide Lys-Pro-Val and corresponds to the C-terminal tripeptide of α-melanocyte-stimulating hormone. The short name does not specify salt, terminal form, water…
Updated September 8, 2026Knowledge tools
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Selected: KPV5 · 5 mg × 10 vials
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.
